GENE ONLINE|News &
Opinion
Blog

Feature
COVID-19 Vaccine
Vaccines Developing Can Catch Up SARS-CoV-2 Mutating?
2020-09-12
COVID-19 Vaccine
Cooperation of Two Chinese Pharma Launched Massive Clinical Trials Abroad
2020-09-08
COVID-19 Vaccine
Entering Late into the COVID-19 Vaccine Race, Could this Pharma Duo Measure up to Competition?
2020-09-06
COVID-19 Cas9
Scientists Further Powerful Gene Editing Tech’s Caliber with Rapid, Low Cost COVID-19 Diagnosis
2020-09-06
COVID-19 ELISA
COVID-19: An Improved ELISA Test for Rapid Antibody Detection Provides Edge Over Current Players
2020-09-04
In-Depth Anti-CD38
Spotlight: Infusion-Related Reactions Associated with Rapid Infusion of Daratumumab
2020-08-31
COVID-19 Rapid Test
COVID-19: USFDA Approves Abbott’s $5 Test, BinaxNOW™ for Rapid Diagnosis
2020-08-27
COVID-19
AstraZeneca Initiates Phase 1 Trial of COVID-19 Antibody Treatment in the UK
2020-08-26
COVID-19
USFDA Chief Apologizes For Overstating Benefits of Convalescent Plasma Therapy
2020-08-26
Technology Cancer
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
In-Depth Oncology
OneOncology Enters First-of-its-Kind Partnership with FMI to Advance Personalized Medicine at Community Oncology Practices
2020-08-18
COVID-19
CureVac Shares Catapult 494% Following Successful IPO Debut
2020-08-18
R&D
Altering the Treatment Landscape of Neurodegenerative Diseases Using Antisense Oligonucleotides (ASOs)
2020-08-17
COVID-19 Vaccine
COVID-19 Vaccine: Russia Announces Approval of “Sputnik V” Despite Concerns Over Safety
2020-08-12
Combating the Pandemic via AI and Diagnostics: Highlights from the “TAIWAN is Helping: AI x Pandemic Prevention Online Forum”
2020-08-11Partner
1 … 47 48 49 50 51 … 60
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top